SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.

COVIDSurg, Collaborative; GlobalSurg, Collaborative (2022). SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia, 77(1), pp. 28-39. Association of Anaesthetists 10.1111/anae.15563

[img]
Preview
Text
Anaesthesia_-_2021_-_-_SARS_u2010CoV_u20102_infection_and_venous_thromboembolism_after_surgery_an_international_prospective_cohort.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (605kB) | Preview

SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. SARS-CoV-2 diagnosis was defined as peri-operative (7 days before to 30 days after surgery); recent (1-6 weeks before surgery); previous (≥7 weeks before surgery); or none. Information on prophylaxis regimens or pre-operative anti-coagulation for baseline comorbidities was not available. Postoperative venous thromboembolism rate was 0.5% (666/123,591) in patients without SARS-CoV-2; 2.2% (50/2317) in patients with peri-operative SARS-CoV-2; 1.6% (15/953) in patients with recent SARS-CoV-2; and 1.0% (11/1148) in patients with previous SARS-CoV-2. After adjustment for confounding factors, patients with peri-operative (adjusted odds ratio 1.5 (95%CI 1.1-2.0)) and recent SARS-CoV-2 (1.9 (95%CI 1.2-3.3)) remained at higher risk of venous thromboembolism, with a borderline finding in previous SARS-CoV-2 (1.7 (95%CI 0.9-3.0)). Overall, venous thromboembolism was independently associated with 30-day mortality (5.4 (95%CI 4.3-6.7)). In patients with SARS-CoV-2, mortality without venous thromboembolism was 7.4% (319/4342) and with venous thromboembolism was 40.8% (31/76). Patients undergoing surgery with peri-operative or recent SARS-CoV-2 appear to be at increased risk of postoperative venous thromboembolism compared with patients with no history of SARS-CoV-2 infection. Optimal venous thromboembolism prophylaxis and treatment are unknown in this cohort of patients, and these data should be interpreted accordingly.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Thoracic Surgery

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1365-2044

Publisher:

Association of Anaesthetists

Language:

English

Submitter:

Thomas Michael Marti

Date Deposited:

19 Jan 2022 12:27

Last Modified:

11 May 2022 08:13

Publisher DOI:

10.1111/anae.15563

PubMed ID:

34428858

Additional Information:

COVIDSurg Collaborative, GlobalSurg Collaborative: Gregor Kocher

Uncontrolled Keywords:

COVID-19 SARS-CoV-2 deep vein thrombosis pulmonary embolism venous thromboembolism

BORIS DOI:

10.48350/162951

URI:

https://boris.unibe.ch/id/eprint/162951

Actions (login required)

Edit item Edit item
Provide Feedback